Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 203.80M | £ 279.30M | £ 137.00M | £ 287.60M | £ 79.90M |
Total Assets | £ 7.14B | £ 6.67B | £ 6.40B | £ 6.63B | £ 2.36B |
Total Debt | £ 911.90M | £ 779.90M | £ 771.90M | £ 765.80M | £ 84.20M |
Net Debt | £ 708.10M | £ 500.60M | £ 634.90M | £ 478.20M | £ 4.30M |
Total Liabilities | £ 1.47B | £ 1.46B | £ 1.27B | £ 1.44B | £ 490.50M |
Stockholders Equity | £ 5.67B | £ 5.21B | £ 5.14B | £ 5.19B | £ 1.87B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |